Susceptibility of Multiply Antibiotic-Resistant Pneumococci to the New Beta-Lactam Drugs and Rosaramicin
Open Access
- 1 April 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 19 (4) , 675-677
- https://doi.org/10.1128/aac.19.4.675
Abstract
Eight new beta-lactam antibiotics and rosaramicin were tested for their activity against penicillin-susceptible and multiply resistant pneumococci. All of the beta-lactam drugs were 50- to 150-fold less active against the drug-resistant pneumococci when compared with their activity against penicillin-susceptible pneumococci. Rosaramicin activity was similar to that of erythromycin.This publication has 2 references indexed in Scilit:
- Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluidThe American Journal of Medicine, 1980
- Emergence of Multiply Resistant PneumococciNew England Journal of Medicine, 1978